What should you know about NMIBC bladder cancer?

NMIBC bladder cancer is a bladder lining cancer that has not grown into the bladder muscle and needs planned follow-up. The abbreviation means non-muscle-invasive bladder cancer. The exact grade, number, size, and appearance of tumours guide decisions, and recurrence monitoring is part of care.

A clinician usually confirms the diagnosis by examining tissue removed during a procedure, often after a [Cystoscopy](/treatments/diagnostics-and-staging/cystoscopy/). NMIBC can be low, intermediate, or high risk according to features that affect the chance of returning or progressing. Blood in the urine, urgency, or [Difficulty Passing Urine](/symptoms/difficulty-passing-urine/) can occur, but these symptoms also have non-cancer causes.

Treatment commonly starts with removing visible tumour through the urinary passage. Depending on the findings, care may include medicine placed directly into the bladder, such as [Intravesical BCG Therapy](/treatments/systemic-therapy/intravesical-bcg-therapy/), or other bladder medicines. More extensive disease may lead to discussion of [Bladder Removal Surgery](/treatments/surgical-oncology/cystectomy/), chemotherapy, or immunotherapy. Keep every cystoscopy and follow-up appointment.

Contact your care team promptly for heavy or persistent blood in the urine, clots, inability to pass urine, fever, chills, or worsening pain after a bladder procedure or treatment. Inability to pass urine with severe lower abdominal pain needs urgent assessment. Do not wait for a routine surveillance appointment when these symptoms appear.

Ask which grade and risk group applies, whether the muscle was sampled, why a particular bladder treatment is recommended, and how surveillance cystoscopies will be scheduled. Ask what symptoms after treatment should trigger a same-day call.